About CUBEBIO

As a biomedical company dedicated to research and development of in vitro diagnostics for early cancer detection,
we will become the world's best company by contributing to the promotion of people's health and happiness.

partner

Partners

  • 분당서울대병원
  • 이화여대의료원
  • Asan Medical Center
  • Samsung Securities
  • Jacobson
  • Standart-Biotest
  • National Medical Research Radiological Centre
  • WAVICE
  • TAIWAN

Seoul National University Hospital

SNUH consists of a children hospital, cancer hospital, and a medical life research institute, etc. Bed count of 1,751, around 9,000 outpatients per day on average 8,000 medical staff including 1,800 operating doctors

Ehwa Womens University Medical Center

A medical institution established in 1887 with a long history and tradition as the "House of Many Sick Women”, Korea’s first women’s hospital Developed differentiated competitiveness by specializing in female cancers such as breast cancer, thyroid cancer, uterine cancer, and ovarian cancer through the strengths accumulated in the study from the women's education, diagnosis, and research Focuses on providing differentiated medical services for severe diseases such as bladder cancer, stomach cancer, colon cancer, cardiovascular disease, and chronic adult diseases such as high blood pressure, diabetes, and obesity Bed count of 1,721 and 626 operating doctors

Asan Medical Center

The most popular hospital with over 60,000 visitors per day on average No. 1 hospital in performing highly sophisticated surgeries on 9 major cancers and other diseases The International Healthcare Center for international patients whose number has been continuously increasing from 6,182 (2010) to 11,911 (2013), 17,999 (2018) Possessing the highest number of beds in South Korea as a single hospital (2,705 beds in Seoul and 1,748 beds in other branches) Joint research and development with internationally prestigious research institutions, such as Dana-Farber Cancer Institute (US), University of Minnesota (US), Korea Institute of Science and Technology (South Korea), etc.

Samsung Securities

Underwriting IPOs of various biomedical firms expected to be worth billions of dollars in 2020 Building a balanced business portfolio across the enterprise through diversification of revenue sources by strengthening business capabilities in the wholesale and IB sectors AA+ rating (stable outlook recorded by 3 rating agencies) Signed an MOU with Montreal-based institutional investor, Caisse de depot et placement du Quebec (CDPQ), in relation to infrastructure investment in 2019, thereby becoming the first domestic financial investment company to have partnered with a globally renowned pension fund

Jacobson Pharma Group

Jacobson Pharma Group(HK Stock code: 2633, 2161) is one of the biggest generic pharmaceutical company Owns Vast amount of distribution, sales route around China & South East Asia region Occupies more than 30% of generic medicine market throughout the region and runs various types of businesses from GMP pharmaceutical business to HongKong-China trade business. Jacobson Pharma Group and CUBEBIO signed ₩100Bn worth export contract towards Hongkong, Macao, Taiwan, Indonesia, Malaysia, Thailand, Vietnam and Philippines for 3years.

《Standart-Biotest》 LLC (Russia)

《Standart-Biotest》 LLC is a Russian corporation conducting the production of medicinal supplies and the wholesale business of pharmaceutical products, medical machinery, devices, and equipment.

National Medical Research Radiology Center (Russia)

The largest medical center in the field of oncology, radiology, and urology as the Federal State Budgetary Institution (FSBI) of the Ministry of Health of the Russian FederationConsisting of Hertsen Moscow Oncology Research Institute, Tsyb Medical Radiological Research Center, and Lopatkin Scientific Research Institute of Urology and Interventional Radiology.905 beds and over 3,300 medical professionals, including 615 scientific researchers, 400 medical doctors, and 980 nurses.Over 22,000 surgeries, over 100,000 outpatient consultations, and over 60% high-tech medical care every year.Partnerships with international organizations, such as the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), the International Atomic Energy Agency (IAEA), the Organization of European Cancer Institutes (OECI), the European Organization for Research and Treatment of Cancer (EORTC), and the Union for International Cancer Control (UICC).Partnerships with international research centers, hospitals, and educational facilities, like the National Cancer Center (US), University of Hiroshima (Japan), Peking University (China) and University of Hamburg (Germany).

WAVICE

A company specializing in the development and production of compound semiconductors and application modules based on RF GaN which is a core technology of future surveillance and reconnaissance weapons systems and 5G The only RF Gan Fab in Korea Participated in defense projects to establish a technology across all RF GaN

TAIWAN BIOTECH GROUP

The first local pharmaceutical company in Taiwan founded in 1945 Covers a wide range of business areas including medical devices, pharmacy chains, vitamins and dietary supplements, investment, etc. Runs its business in 16 different countries, especially in America and Asia regions

FPA

Incorporated as a subsidiary of CUBEBIO A company specialized in developing automation equipment that supplies automation equipment and solutions in high-tech industries such as displays, semiconductor manufacturing equipment, future cars (electric/hydrogen vehicles, secondary cell), solar energy, smart factory, camera module, medical device, etc. Top company in equipment related to organic light-emitting diode thin film materials Major clients include Samsung Group (Samsung Electronics, Samsung Display, Samsung SDI), Hanwha Group (Hanwha/Mechanical, Hanwha QCells), LG Group (LG Chemical), BOE, etc.